ClinVar Miner

Submissions for variant NM_000527.5(LDLR):c.1268T>C (p.Ile423Thr)

gnomAD frequency: 0.00001  dbSNP: rs879254849
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
LDLR-LOVD, British Heart Foundation RCV000238040 SCV000295334 likely pathogenic Hypercholesterolemia, familial, 1 2016-03-25 criteria provided, single submitter literature only
Centre de Génétique Moléculaire et Chromosomique, Unité de génétique de l'Obésité et des Dyslipidémies, APHP, GH Hôpitaux Universitaires Pitié-Salpêtrière / Charles-Foix RCV000238040 SCV000503326 likely pathogenic Hypercholesterolemia, familial, 1 2016-12-16 criteria provided, single submitter clinical testing subjects mutated among 2600 FH index cases screened = 15 , family members = 6 with co-segregation / variant systematically associated with c.798T>A, p.Asp266Glu / Software predictions: Conflicting
Cardiovascular Research Group, Instituto Nacional de Saude Doutor Ricardo Jorge RCV000238040 SCV000599370 pathogenic Hypercholesterolemia, familial, 1 2016-03-01 criteria provided, single submitter curation
Labcorp Genetics (formerly Invitae), Labcorp RCV001384956 SCV001584659 pathogenic Familial hypercholesterolemia 2020-03-04 criteria provided, single submitter clinical testing This sequence change replaces isoleucine with threonine at codon 423 of the LDLR protein (p.Ile423Thr). The isoleucine residue is highly conserved and there is a moderate physicochemical difference between isoleucine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individual(s) with familial hypercholesterolemia (PMID: 7635461, 24722143, 11005141, 10884919, Invitae). It has also been observed to segregate with disease in related individuals. This variant is also known as p.I402T in the literature. ClinVar contains an entry for this variant (Variation ID: 251760, 430765). This variant has been reported to affect LDLR protein function (PMID: 10884919). For these reasons, this variant has been classified as Pathogenic.
Ambry Genetics RCV002446477 SCV002682617 pathogenic Cardiovascular phenotype 2018-03-06 criteria provided, single submitter clinical testing The p.I423T pathogenic mutation (also known as c.1268T>C), located in coding exon 9 of the LDLR gene, results from a T to C substitution at nucleotide position 1268. The isoleucine at codon 423 is replaced by threonine, an amino acid with similar properties. This alteration (historically described as p.I402T) has been reported in individuals with familial hypercholesterolemia and segregated with the disease in two apparently unrelated families (Ekström U et al. MP, Mol. Pathol., 2000 Feb;53:31-6; Khoo KL et al. Clin. Genet., 2000 Aug;58:98-105; Amsellem S et al. Hum. Genet., 2002 Dec;111:501-10; Wu WF et al. PLoS ONE, 2014 Apr;9:e94697). In addition, functional studies have suggested that this alteration would cause reduced protein activity in LDL binding and degradation (Ekström U et al. MP, Mol. Pathol., 2000 Feb;53:31-6). Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation.
Juno Genomics, Hangzhou Juno Genomics, Inc RCV000238040 SCV005418438 pathogenic Hypercholesterolemia, familial, 1 criteria provided, single submitter clinical testing PM2_Supporting+PS3+PS4_Moderate+PP4+PM3
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum RCV000238040 SCV000606378 pathogenic Hypercholesterolemia, familial, 1 no assertion criteria provided research

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.